Skip to Main Content
Our Commitment to Diversity

News & Events

Event

Share via LinkedIn
Share via Twitter
Share via Facebook

Transforming Health: Digital Health Legal Insight Series 2022, Parts I and II: D2C Telehealth Services

KL Gates Hosted Event
Date: 29 March 2022 and 12 April 2022
Time: 12:00 PM - 1:00 PM ET
Location: via Webinar

Please join us for a webinar panel series on digital health topics addressing top-of-mind trends and changes in the health care industry. 

First in the series will feature a two-part discussion examining one of the health care industry’s most emergent areas, the delivery of health care services through telehealth: 

Direct-to-Consumer (D2C) Telehealth Services: Legal and Regulatory Considerations (Parts I and II)

Legal industry leaders and K&L Gates partners Gina Bertolini and Leah D'Aurora Richardson - currently advising many companies both large and small in this evolving field - will discuss legal, structural and operational issues in providing D2C telehealth services. More information about Parts I and II, and the opportunity to RSVP, are below.

Part I - D2C Telehealth Services: Legal and Regulatory Considerations 

Join us on Tuesday, 29 March at 12:00 P.M. for Part I of the series, which will address corporate practice and other structural considerations; regulatory gatekeeping matters, such as modality and prescribing authority; and data privacy.

Register here.

Part II - D2C Telehealth Services: Legal and Regulatory Considerations 

Join us on Tuesday, 12 April at 12:00 P.M. for Part II of the series, which will address fraud and abuse considerations, licensure, informed consent, and patient-facing communications.

Register here.

Additional topics in our Transforming Health: Digital Health Legal Insights 2022 series include:

  • Digital Health Deals: Why Privacy and Cybersecurity are Necessary Components of Any Digital Health M&A Transaction
  • The Impact of Recent Developments Under the TCPA on Health Care Providers

Stay tuned for future dates.

Find more items tagged as: Digital Health, Health Care and FDA, Health Care Sector, Policy and Regulatory
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel